Subjects:
Free Research Articles
On page 676 in the paragraph that begins “The second-generation BTKi acalabrutinib,” the last sentence “Notably, in the subgroup of 26 patients with blastoid/pleomorphic MCL, PFS was 15.2%” should read “Notably, in the subgroup of 26 patients with blastoid/pleomorphic MCL, median PFS was 15.2 months.”
© 2025 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
2025
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal